← back to search

Işıl Altıntaş

Utrecht University · NL
🔎 Find collaborators in Radiology, Nuclear Medicine and Imaging · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research focused on Cancer research and Micelle, with related work in Endocytosis, Immunotherapy, T cell. Notable publications include 'Glucocorticoid‐Loaded Core‐Cross‐Linked Polymeric Micelles with Tailorable Release Kinetics for Targeted Therapy of Rheumatoid Arthritis', 'Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells', and 'Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors'.
h-index
citations
505
works
6
NIH funding
primary concept
email

Recent publications

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Cancer Discovery 2022cited by 110position: middledoi
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
Journal for ImmunoTherapy of Cancer 2022cited by 36position: middledoi
Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles
Biomaterials 2013cited by 86position: middledoi
Inhibition of Tumor Growth by Targeted Anti-EGFR/IGF-1R Nanobullets Depends on Efficient Blocking of Cell Survival Pathways
Molecular Pharmaceutics 2013cited by 37position: middledoi
Glucocorticoid‐Loaded Core‐Cross‐Linked Polymeric Micelles with Tailorable Release Kinetics for Targeted Therapy of Rheumatoid Arthritis
Angewandte Chemie International Edition 2012cited by 123position: middledoi
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Journal of Controlled Release 2012cited by 113position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Wim E. Hennink · Utrecht University4 papers (2012–2013)Raymond M. Schiffelers · Utrecht University4 papers (2012–2013)Robbert J. Kok · Utrecht University3 papers (2012–2013)Paul M.P. van Bergen en Henegouwen · Utrecht University3 papers (2012–2013)Raimond Heukers · Utrecht University3 papers (2012–2013)Roy van der Meel · Eindhoven University of Technology2 papers (2012–2013)Gert Storm · University of Applied Sciences Utrecht2 papers (2012–2013)Maryam Amidi · Utrecht University1 papers (2012–2012) · 1 papers (2022–2022)Sabrina Oliveira · Utrecht University1 papers (2013–2013)Özlem Türeci · Helmholtz Institute for Translational Oncology Mainz1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Rob Haselberg · Utrecht University1 papers (2013–2013)Richard A. Pepermans · Utrecht University1 papers (2013–2013)Sebastian Kreiter · Gutenberg College1 papers (2022–2022) · 1 papers (2022–2022)Maria Jure‐Kunkel · Genmab (United States)1 papers (2022–2022)John A. W. Kruijtzer · Utrecht University1 papers (2012–2012)Saskia M. Burm · Utrecht University1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Radiology, Nuclear Medicine and Imaging · Oncology →